Blood

Scientists at the Dana-Farber Cancer Institute have published a study describing a new type of blood test that can detect more than 20 types of cancer with a high degree of accuracy. Not only that, it can even trace them back to their source.

New research has discovered how gut bacteria can directly influence blood sugar levels by promoting the synthesis of gut-derived serotonin.

Scientists have developed a new prostate cancer blood test that promises significant increases in accuracy compared to current blood tests.

Provocative study suggests blood tests can predict a person's risk of dying within the next 10 years.

A new blood test has been developed that promises to be able to effectively track the progression of breast cancer at its earliest stages. It is suggested the blood test could track the efficacy of drug therapies better than current imaging techniques and prevent unnecessary surgical procedures.

A new research breakthrough uncovering the very earliest inflammatory mechanism triggered in celiac sufferers after consuming gluten could lead to be novel blood test making it substantially easier for clinicians to diagnose the disease.

Alkahest, a California-based start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.

A new study is suggesting a novel blood test can identify subjects at an early stage of Alzheimer’s disease, years before any symptoms appear. The blood test may even be more accurate than PET brain scans, and is hoped to accelerate patient screening for clinical trials.

A study is building on the association between the liver and Alzheimer’s . Suggesting a correlation between blood-based liver function biomarkers and several neurological signs of Alzheimer’s, the research hypothesizes the disease to have broader metabolic effects in organs other than the brain.

The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.

A patient’s immune system can often react badly to bone marrow transplants. Mesenchymal stromal cells (MSCs) may help, but they too can be cleared out by immune cells. Now, a Harvard team has shown that coating MSCs in a thin hydrogel can protect them, making bone marrow transplants more successful.

There exists a group of HIV-positive people who have a rare ability to naturally control the HIV infection. Now, after years of research, a team of scientists from the Institut Pasteur in Paris, has successfully reprogrammed cells that lack this ability, giving them the same, antiviral potency.